Involvement of the dual-specificity phosphatase M3/6 in c-Jun N-terminal kinase inactivation following cerebral ischemia in the rat hippocampus

References

• Nordle AK, Rios P, Gaulton A, Functional assignment of MAPK phosphatase domains. Proteins 2007;69(1): 19–31.
   PubMedGoogle Scholar
• Cotsiki M, Oehrl W, Samiotaki M, Phosphorylation of the M3/6 dual-specificity phosphatase enhances the activation of JNK by arsenite. Cell Signal 2012;24(3): 664–76.
   PubMedGoogle Scholar
• Mehta SL, Manhas N, Raghubir R. Molecular targets in cerebral ischemia for developing novel therapeutics. Brain Res Rev 2007;54(1):34–66.
   PubMedGoogle Scholar
• Gao Y, Signore AP, Yin W, Neuroprotection against focal ischemic brain injury by inhibition of c-Jun N-terminal kinase and attenuation of the mitochondrial apoptosis-signaling pathway. J Cereb Blood Flow Metab 2005;25(6): 694–712.
   PubMed Web of Science ®Google Scholar
• Repici M, Mare L, Colombo A, c-Jun N-terminal kinase binding domain-dependent phosphorylation of mitogen-activated protein kinase kinase 4 and mitogen-activated protein kinase kinase 7 and balancing cross-talk between c-Jun N-terminal kinase and extracellular signal-regulated kinase pathways in cortical neurons. Neuroscience 2009;159(1): 94–103. Epub 2008 Dec 14.
   PubMedGoogle Scholar
• Guan QH, Pei DS, Liu XM, Neuroprotection against ischemic brain injury by SP600125 via suppressing the extrinsic and intrinsic pathways of apoptosis. Brain Res. 2006;1092(1):36–46. Epub 2006 May 3.
   PubMedGoogle Scholar
• Uehara T, Bennett B, Sakata ST, JNK mediates hepatic ischemia reperfusion injury. J Hepatol. 2005;42(6):850–9. Epub 2005 Apr 7.
   PubMed Web of Science ®Google Scholar
• Lee S, Yoon S, Kim DH. A high nuclear basal level of ERK2 phosphorylation contributes to the resistance of cisplatin-resistant human ovarian cancer cells. Gynecologic Oncology 2007;104(2):338–44.
   PubMed Web of Science ®Google Scholar
• Liu J, Lin A. Role of JNK activation in apoptosis: a double-edged sword. Cell Res 2005;15(1):36–42.
   PubMed Web of Science ®Google Scholar
• Dhillon AS, Hagan S, Rath O, Kolch W. MAP kinase signalling pathways in cancer. Oncogene 2007;26(22): 3279–90.
   PubMed Web of Science ®Google Scholar
• Johnson GL, Nakamura K. The c-jun kinase/stress-activated pathway: regulation, function and role in human disease. Biochim Biophys Acta 2007;1773(8):1341–8.
   PubMed Web of Science ®Google Scholar
• Ji RR, Gereau RW 4th, Malcangio M, Strichartz GR. MAP kinase and pain. Brain Res Rev. 2009;60(1): 135–48.
   PubMedGoogle Scholar
• Milano A, Montesano Gesualdi N, Teperino R, Oxidative DNA damage and activation of c-Jun N-terminal kinase pathway in fibroblasts from patients with hereditary spastic paraplegia. Cell Mol Neurobiol 2005;25(8):1245–54.
   PubMedGoogle Scholar
• Owen GR, Achilonu I, Dirr HW. High yield purification of JNK1β1 and activation by in vitro reconstitution of the MEKK1→MKK4→JNK MAPK phosphorylation cascade. Protein Expr Purif 2012;pii:S1046–5928(12)00299–9. doi: 10.1016/j.pep.2012.10.010. [Epub ahead of print]
   Google Scholar
• Molkentin JD. Calcineurin-NFAT signaling regulates the cardiac hypertrophic response in coordination with the MAPKs. Cardiovasc Res 2004;63(3):467–75.
   PubMed Web of Science ®Google Scholar
• Sun BK, Kim JH, Nguyen HN, MEKK1/MEKK4 are responsible for TRAIL-induced JNK/p38 phosphorylation. Oncol Rep 2011;25(2):537–44. doi: 10.3892/or.2010.1079. Epub 2010 Dec 7.
   PubMedGoogle Scholar
• Engström W, Ward A, Moorwood K. The role of scaffold proteins in JNK signalling. Cell Prolif 2010;43(1):56–66. Epub 2009 Nov 17.
   PubMed Web of Science ®Google Scholar
• Nakagawa K, Sugahara M, Yamasaki T, Filamin associates with stress signalling kinases MKK7 and MKK4 and regulates JNK activation. Biochem J 2010;427(2): 237–45.
   PubMedGoogle Scholar
• Nadeau PJ, Charette SJ, Landry J. REDOX reaction at ASK1-Cys250 is essential for activation of JNK and induction of apoptosis. Mol Biol Cell 2009;20:3628–37.
   PubMed Web of Science ®Google Scholar
• Park HS, Kim MS, Huh SH, Akt (protein kinase B) negatively regulates SEK1 by means of protein phosphorylation. J Biol Chem 2002;277(4):2573–8.
   PubMedGoogle Scholar
• Zhang QG, Wang XT, Han D, Akt inhibits MLK3/JNK3 signaling by inactivating Rac1: a protective mechanism against ischemic brain injury. J Neurochem 2006;98(6): 1886–98.
   PubMedGoogle Scholar
• Jeffrey KL, Camps M, Rommel C, Mackay CR. Targeting dual-specificity phosphatases: manipulating MAP kinase signalling and immune responses. Nat Rev Drug Discov 2007;6(5):391–403.
   PubMed Web of Science ®Google Scholar
• Stankov K, Bogdanovic G, Stankov S, Expression analysis of genes involved in apoptosis, proliferation and endoplasmic reticulum stress in ionomycin/PMA treated Jurkat cells. J BUON 2012;17(2):369–76.
   PubMedGoogle Scholar
• Palacios C, Collins MK, Perkins GR. The JNK phosphatase M3/6 is inhibited by protein-damaging stress. Curr Biol 2001;11(18):1439–43.
   PubMedGoogle Scholar
• Lee KH, Lee CT, Kim YW, Preheating accelerates mitogen-activated protein (MAP) kinase inactivation post-heat shock via a heat shock protein 70-mediated increase in phosphorylated MAP kinase phosphatase-1. J Biol Chem 2005;280(13):13179–86.
   PubMedGoogle Scholar
• Merienne K, Helmlinger D, Perkin GR, Polyglutamine expansion induces a protein-damaging stress connecting heat shock protein 70 to the JNK pathway. J Biol Chem 2003;278(19):16957–67.
   PubMedGoogle Scholar
• Cui Z, Wang P, Sun L, Lipopolysaccharide-evoked HSPA12B expression by activation of MAPK cascade in microglial cells of the spinal cord. J Neurol Sci 2010;294(1–2):29–37.
   PubMed Web of Science ®Google Scholar
• Okami N, Narasimhan P, Yoshioka H, Prevention of JNK phosphorylation as a mechanism for rosiglitazone in neuroprotection after transient cerebral ischemia: activation of dual specificity phosphatase. J Cereb Blood Flow Metab. 2012;33:106–14.
   PubMedGoogle Scholar
• Owens DM, Keyse SM. Differential regulation of MAP kinase signalling by dual-specificity protein phosphatases. Oncogene 2007;26(22):3203–13.
   PubMed Web of Science ®Google Scholar
• Maslov LN, Lishmanov IuB. Neuroprotective effect of ischemic postconditioning and remote preconditioning. Prospective of clinical use. Angiol Sosud Khir 2012;18(2): 27–34.
   PubMedGoogle Scholar
• Biermann J, Lagrèze WA, Schallner N, Inhalative preconditioning with hydrogen sulfide attenuated apoptosis after retinal ischemia/reperfusion injury. Mol Vis. 2011;17:1275–86. Epub 2011 May 7.
   PubMedGoogle Scholar
• Vallerie SN, Hotamisligil GS. The role of JNK proteins in metabolism. Transl Med 2010;2(61):60–5.
   Google Scholar
• Heasley LE, Han SY. JNK regulation of oncogenesis. Mol Cells 2006;21(2):167–73.
   PubMed Web of Science ®Google Scholar
• Du Y, Li C, Hu WW, Neuroprotection of preconditioning against ischemic brain injury in rat hippocampus through inhibition of the assembly of GluR6-PSD95-mixed lineage kinase 3 signaling module via nuclear and non-nuclear pathways. Neuroscience 2009;161(2):370–80. Epub 2009 Mar 26.
   PubMedGoogle Scholar
• Zhang QG, Wang RM, Han D, Preconditioning neuroprotection in global cerebral ischemia involves NMDA receptor-mediated ERK-JNK3 crosstalk. Neurosci Res 2009;63(3):205–12.
   PubMedGoogle Scholar
• Zeng XW, Li MW, Pan J, Activation of c-Jun N-terminal kinase 1/2 regulated by nitric oxide is associated with neuronal survival in hippocampal neurons in a rat model of ischemia. Chin Med J (Engl) 2011;124(20):3367–72.
   PubMedGoogle Scholar
• Zhao H, Sapolsky RM, Steinberg GK. Phosphoinositide-3-kinase/akt survival signal pathways are implicated in neuronal survival after stroke. Mol Neurobiol 2006;34(3):249–70.
   PubMed Web of Science ®Google Scholar
• Theodosiou A, Ashworth A. Differential effects of stress stimuli on a JNK-inactivating phosphatase. Oncogene 2002;21(15):2387–97.
   PubMedGoogle Scholar
• Bironaite D, Pivoriunas A, Venalis A. Upregulation of iHsp70 by mild heat shock protects rabbit myogenic stem cells: Involvement of JNK signaling and c-Jun. Cell Biol Int 2012;36:1089–96.
   PubMedGoogle Scholar